Intravenous peramivir for treatment of influenza in hospitalized patients.

@article{Ison2014IntravenousPF,
  title={Intravenous peramivir for treatment of influenza in hospitalized patients.},
  author={Michael G Ison and Joseph Fraiz and Barry N Heller and Luis Jauregui and Graham Mills and William D. O'Riordan and Brian O'Neil and Elliott Geoffrey Playford and J. Douglass Rolf and Eduardo Sada-D{\'i}az and Jenna Elder and Phil Collis and J. Esteban Hern{\'a}ndez and W P Sheridan},
  journal={Antiviral therapy},
  year={2014},
  volume={19 4},
  pages={349-61}
}
BACKGROUND Influenza causes over 200,000 hospitalizations a year in the United States, but few antiviral treatment studies have focused on patients hospitalized with influenza. This open-label, randomized study was initiated during the 2009 H1N1 pandemic to help assess the antiviral activity, safety and tolerability of 5-10 days treatment with two different dosing regimens of the intravenous neuraminidase inhibitor, peramivir, in hospitalized subjects with influenza. METHODS Quantitative… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
12 Citations
40 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

and Drug Administration

  • US Foo
  • Emergency use authorization of peramivir IV fact…
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…